Resistant Hypertension

Primary Care - Clinics in Office Practice

Volumn 35, Issue 3, 2008, Pages 501-513

  Silverstein, Russell L ^a   Ram, C Venkata S ^b  

^a Dallas Nephrology Associates   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; COCAINE; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GUANETHIDINE; HYDROCHLOROTHIAZIDE; INDOMETACIN; LOOP DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLPROPANOLAMINE; PROPRANOLOL; RIFAMPICIN; TRICYCLIC ANTIDEPRESSANT AGENT;

ALCOHOL CONSUMPTION; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CIGARETTE SMOKING; CLINICAL ASSESSMENT; CLINICAL EVALUATION; DISEASE CLASSIFICATION; HUMAN; HYPERTENSION; HYPERVOLEMIA; MORBIDITY; MORTALITY; OBESITY; PREVALENCE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; REVIEW; RISK FACTOR; SALT INTAKE; SLEEP APNEA SYNDROME; SODIUM RETENTION; TREATMENT REFUSAL; TREATMENT RESPONSE; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHRONIC DISEASE; DIURETICS; DRUG INTERACTIONS; HUMANS; HYPERTENSION; LIFE STYLE; MEDICAL HISTORY TAKING; PATIENT EDUCATION AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; UNITED STATES;

EID: 49349103586     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2008.03.002     Document Type: Review

References (40)

1. Chobanian A.V., Bakris G.L., Black H.R., et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heat, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection. Evaluation and Treatment of High Blood Pressure. Hypertension 41 (2003) 1206-1252
2. Hyman D., and Pavlik V. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med 345 (2001) 479-486
3. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to Angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
4. Cushman W.C., Ford C.E., Cutler J.A., et al., for the ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heat Attack Trial (ALLHAT). J Clin Hypertens (Greenwich) 4 (2002) 393-404
5. Black H.R., Elliott W.J., Grandits G., et al., for the CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 289 (2003) 2073-2082
6. Julius S., Kjeldsen S.E., Brunner H., et al., for the VALUE Trial. VALUE trial: Long-term blood pressure trends in 12,449 patients with hypertension and high cardiovascular risk. Am J Hypertens 16 (2003) 544-548
7. Thibonnier M. Ambulatory blood pressure monitoring: when is it warranted?. Postgrad Med 91 (1992) 263-274
8. Veglio F., Rabbia F., Riva P., et al. Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension. Clin Exp Hypertens 23 3 (2001) 203-211
9. Verdecchia P. Using out of office blood pressure monitoring in the management of hypertension. Curr Hypertens Rep 3 5 (2001) 400-405
10. Messerli F.H., Ventura H.O., and Amodeo C. Osler's maneuver and pseudohypertension. N Engl J Med 312 (1985) 1548-1551
11. Mejia A.D., Egan B.M., Schork N.J., et al. Artifacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension. Ann Intern Med 112 (1990) 270-277
12. Dustan H.P., Tarazi R.M., and Bravo E.L. Dependence of arterial pressure on intravascular volume in treated hypertensive patients. N Engl J Med 286 (1972) 861-866
13. Fierro-Carrion G., and Ram C.V.S. Nonsteriodal anti-inflammatory drugs (NSAIDs) and blood pressure. Am J Cardiol 80 (1997) 775-776
14. Bloxham C.A., Beevers D.G., and Walker J.M. Malignant hypertension and cigarette smoking. Br Med J 1 (1997) 581-583
15. Lavie P., and Hoffstein V. Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 24 6 (2001) 721-725
16. Logan A.G., Perlikowski S.M., mente A., et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19 (2001) 2271-2277
17. Peppard P.E., Young T., Palta M., et al. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342 (2000) 1378-1384
18. Calhoun D.A., Nishizaka M.K., Zaman M.A., et al. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125 (2004) 112-117
19. Calhoun D.A., Nishizaka M.K., Zaman M.A., et al. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40 (2002) 892-896
20. Duprez D.A. Role of the rennin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens 24 (2006) 983-991
21. Duprez D., De Buyzere M., Rietzschel E.R., et al. Aldosterone and vascular damage. Curr Hypertens Rep 2 (2002) 327-334
22. Schiffrin E.L. Effects of aldosterone on the vasculature. Hypertension 47 (2006) 312-318
23. van Jaarsveld B.C., Krijnen P., Derkx F.H., et al. Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens. J Hum Hypertens 15 10 (2001) 669-676
24. White W.B. Expanding the use of ambulatory blood pressure monitoring for the diagnosis and management of patients with hypertension. Hypertension 47 (2006) 14-15
25. Clement D.L., De Buyzere M.L., De Bacquer D.A., et al., for the Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 348 (2003) 2407-2415
26. Kikuya M., Ohkubo T., Asayama K., et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama Study. Hypertension 45 (2005) 240-245
27. Felmeden D.C., and Lip G.Y. Resistant hypertension and the Birmingham hypertension square. Curr Hypertens Rep 3 3 (2001) 203-208
28. Nuesch R., Schroeder K., Dieterle T., et al. Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 323 7305 (2001) 142-146
29. Setaro J., and Black H. Refractory hypertension. N Engl J Med 327 (1992) 534-547
30. Eraker S., Kirscht J., and Becker M. Understanding and improving patient compliance. Ann Intern Med 100 (1984) 258-268
31. Cuspidi C., Macca G., Sampieri L., et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 19 11 (2001) 2063-2070
32. Moser M., and Setaro J. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med 355 (2006) 385-392
33. Sartori M., Calo L.A., Mascagna V., et al. Aldosterone and refractory hipertensión: a prospective cohort study. Am J Hypertens 19 (2006) 373-379
34. Epstein M. Aldosterone blockade: an emerging strategy for abrogating progressive renal disease. Am J Med 119 (2006) 912-919
35. Gaddam K.K., Pratt-Ubunama M.N., and Calhoun D.A. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension. Expert Rev Cardiovasc Ther 4 (2006) 353-359
36. Calhoun D.A. Use of aldosterone antagonists in resistant hypertension. Prog Cardiovasc Dis 48 (2006) 387-396
37. Wolk R., and Somers V.K. Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab 8 (2006) 250-260
38. Drager L.F., Pereira A.C., Barreto-Filho J.A., et al. Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea. J Hum Hypertens 20 (2006) 523-528
39. Norman D., Loredo J.S., Nelesen R.A., et al. Effects of continuous positive airway pressure versus supplemental oxygen on 24 hour ambulatory blood pressure. Hypertension 47 (2006) 840-845
40. Mellen P.B., Gao S.K., Vitolins M.Z., et al. Deteriorating dietary habits among adults with hypertension. Arch Intern Med 168 3 (2008) 308-314